Predicting Clinical Efficacy with Alzheimer’s Disease iPSC Panels
Unlocking the Secrets of Alzheimer’s, Epilepsy, and More with Cutting-Edge iPSC Technology
Modeling Neurotoxicity and Neurological Disease using Functional iPSC-derived Neurons
In vitro Model of Alzheimer’s Disease based on Neurons and Astrocytes Generated from Patient iPSCs using Transcription Factor-Based Rapid Differentiation Technology (Society for Neuroscience 2023)
Generation of Alzheimer’s Disease Model Using Human iPSC-derived Neurons and Astrocytes Produced by a Transcription Factor-Based Differentiation Protocol (Neuro4D 2022)
Using Human iPSC-derived Neurons and Astrocytes Produced by Transcription Factor-Based Differentiation Protocols to Generate Models to study Alzheimer’s Disease in vitro (Society for Neuroscience 2022)
Functional evaluation of iPSC-derived astrocytes generated by a rapid differentiation method (Neuro2022 in Japan)
Functional and pharmacological evaluation of iPSC-derived astrocytes generated by a rapid differentiation method (Society for Neuroscience 2022)
Establishment of High-Throughput Toxicity Assay System with iPSC-derived GABAergic Neurons Generated by a Rapid Differentiation Method (Safety Pharmacology Society 2023)
Antibody Validation with mRNA Transfection Into Human Pluripotent Stem Cells
Human iPSC-derived Excitatory Neurons and Astrocytes Differentiated by Quick-Tissue™ Technology for Functional Drug Screening on MEAs
No results found.